"It's speculative, but given their main drug has been approved and the stock's barely budged, I think we could have a real opportunity here," said Jim Cramer on Monday's broadcast.
The stock that's captured Cramer's interest is NPS Pharmaceuticals.
"The stock hasn't rallied much, yet there have been some major positive developments," said Cramer.